Vertebrobasilar Stroke

Earn CME/CE in your profession:

Continuing Education Activity

Vertebrobasilar strokes are interruptions of blood flow to the posterior circulation. While these types of strokes are relatively uncommon, they are a disproportionate cause of morbidity and mortality compared to anterior circulation strokes due to discreet symptoms that resemble non-stroke medical conditions. Patients with a sudden interruption of a vertebrobasilar stroke often present with a chief complaint of nausea or vertigo, delaying appropriate neurological evaluation and preventing or hampering time-dependent interventions. This activity reviews the evaluation, treatment, and management of vertebrobasilar strokes and explains the interprofessional healthcare team's role in improving care for patients with this condition.


  • Describe the pathophysiology of vertebrobasilar strokes.
  • Outline the appropriate evaluation of vertebrobasilar strokes.
  • Review the treatment options available for vertebrobasilar strokes.
  • Summarize the interprofessional team strategies for improving care coordination and communication to advance vertebrobasilar strokes and improve outcomes.


Vertebrobasilar strokes are interruptions of blood flow to the posterior circulation. While these types of strokes are relatively uncommon, they are a disproportionate cause of morbidity and mortality compared to anterior circulation strokes due to discreet symptoms that resemble non-stroke medical conditions. Patients with sudden interruption of a vertebrobasilar stroke often present with the main complaint of nausea or vertigo, which can delay appropriate neurological evaluation and prevent time-dependent interventions. The vertebral and basilar arteries are the main blood vessels that supply the brainstem composed of the midbrain, pons, and medulla. These types of strokes require a specialized interdisciplinary team composed of neurologists, radiologists, emergency physicians, specialized nurses, neurosurgeons, and therapists to diagnose, treat, and effectively manage. A brainstem lesion can be localized by observing the presence of "crossed paresis," which is ipsilateral facial paralysis with contralateral limb hemiparesis and cranial nerve deficits.


Stroke is seen as an "end-stage disease" of multiple chronic and uncontrolled comorbidities. The risk factors of vertebral artery or basal artery stroke are no different from other types of strokes. Hypertension, diabetes mellitus, cigarette smoking, obesity, atrial fibrillation, sedentary lifestyle, hyperlipidemia, illicit drug use such as cocaine, or hypercoagulable states increase the risk of experiencing a stroke. The most common risk factor is hypertension being comorbid in about 70% of patients; however, the likelihood of having as troke increases with multiple comorbidities. Strokes can be divided into ischemic and hemorrhagic, while ischemic strokes can be further delineated into thrombotic, embolic, and lacunar subtypes.[1]

Lacunar strokes are caused by uncontrolled hypertension, which causes decreased perfusion in small vessels located most commonly in the internal capsule, thalamus, or less frequently, the brainstem. Thrombotic strokes are caused by excessive atherosclerotic plaque buildup on the arterial wall, which eventually completely occluded the vessel. Embolic stroke results from a blood clot or a broken off atherosclerotic plaque, which transverses from one area of the cardiovascular system, eventually occluding a part of the cerebrovascular system. Hemorrhagic strokes are commonly caused by aneurysm ruptures, uncontrolled hypertension, arteriovenous malformations, metastasis, amyloid angiopathy.[2][3]


While the mortality and prevalence of stroke have decreased over the past thirty years, from 40% to 33% in 2013, outcomes vary between populations stratified among race, geography, and comorbidities. Stroke is currently the third leading cause of mortality in the United States. Individuals who live in the "stroke belt," which predominately involves the Southeast United States, have a 20% higher mortality than those living outside this geographic area. Women have a higher lifetime risk and mortality than men, although stroke is more common in men. The incidence of stroke is more common in minority populations, specifically Hispanic and Black populations, with mortality occurring in younger individuals on average compared to the White population. An increased lifetime incidence of stroke is seen in those with more comorbidities listed under the etiology section above, with recurrent stroke most common in individuals with multiple uncontrolled risk factors. Posterior circulation strokes have been reported to account for as much as 20% of all strokes.[4][5]


Strokes are brain tissue that has suffered prolonged ischemia from the failure of the sodium-potassium pump in nerve cells to utilize ATP due to an inability to undergo aerobic metabolism. Prolonged ischemia causes lactic acidosis and accumulation of calcium, sodium, and potassium in cells, which causes dysfunction of protein synthesis as well as swelling and eventual disruption of the plasma membrane. The result is the release of cytotoxic free radicals that promote surrounding cell death. In vertebrobasilar strokes, ischemia is most often a result of a thrombus causing severe or complete occlusion of the cerebrovasculature; however, specific syndromes may involve other listed etiologies below.[6]

History and Physical

A stroke of the vertebral or basilar artery should be suspicious in a patient presenting with vestibulocerebellar symptoms, including dizziness, nystagmus, truncal and/or limb ataxia, hypotonia of one side, oscillopsia, or cranial nerve impairment. 

Intracranial Vertebral Arterial Strokes

Lateral medullary infarction (Wallenberg syndrome)

The most common posterior circulation stroke, which is generally the result of atherothrombotic occlusion of the vertebral artery causing ischemia to the lateral part of the medulla. This ischemia impairs the inferior vestibular nucleus, solitary, and ambiguous nuclei, causing the classic presentation of hoarseness, dysphagia, ataxia, and vertigo. The patient can also experience crossed hemianesthesia, indicating a brainstem lesion, with ipsilateral facial sensory loss and contralateral upper and lower extremity anesthesia due to dysfunction of the spinothalamic tract and descending trigeminal tract. This syndrome does not affect muscle strength as the corticospinal tract is located ventrally in the brainstem.[7][8] 

Medial Medullary Infarction (Dejerine syndrome)

Medial medullary infarction is also known as inferior alternating syndrome. It is a result of ischemia to the medial medulla due to occlusion of paramedian branches of the vertebral artery. The classic presentation is ipsilateral tongue paralysis, contralateral limb weakness, contralateral limb anesthesia resulting from impairment to the hypoglossal nerve, dorsal medial lemnisci, and corticospinal pathways. The crossed paralysis localizes the lesion to the brainstem due to ischemia from undecussated corticobulbar fibers located in the medulla.[9][10][11]

Hemimedullary Infarction

This is a rare stroke that involves ischemia to the medial and lateral medullary due to intracranial vertebral artery occlusion proximal to the anterior spinal artery, which results in a combination of symptoms of both lateral and medial medullary syndromes.[12][13]

Cerebellar Infarction (Pseudotumoral Cerebellar Syndrome)

The presenting symptoms depend on the artery that is obstructed. Interruption of the posterior inferior cerebellar artery results in vertigo, truncal ataxia, horizontal nystagmus. The anterior inferior cerebellar artery (AICA) causes dysmetria, loss of hearing on the ipsilateral side, paralysis of the ipsilateral face. Occlusion of the superior cerebellar artery, which receives supply from the basilar artery later discussed in this article, causes dysarthria, ataxia, and vomiting. Space in the posterior fossa is limited, and large cerebellar strokes may cause herniation discussed further in the complications section.[14][15]

Basilar Artery Strokes

Top of the Basilar Syndrome

This is also known as a rostral brainstem infarction is caused by embolic occlusion of the distal basilar artery causing ischemia to the midbrain, temporal, and occipital lobes producing vertical gaze palsy, pupillary palsy, hypersomnolence, abulia, amnesia, and visual hallucinations. Notably, sensory and motor dysfunction is generally not present.[16][17]

Inferior Medial Pontine Syndrome (Foville Syndrome)

Inferior medial pontine syndrome or isolated dorsal pontine tegmentum infarcts is also termed Foville’s syndrome. It results from occlusion of perforating pontine arteries, commonly due to atherosclerosis of the basilar artery. This syndrome results in ipsilateral cranial nerve VI, VII, and contralateral limb hemiparesis and hemianesthesia.[18] 

Ventral Caudal Pontine Infarct (Millard-Gubler Syndrome)

This syndrome most often arises due to mass effect compression of one side of the caudal pons due to tumors, hemorrhage, and infections. It has been observed in younger patients can be caused by demyelinating diseases or viral encephalitis. This compression causes ipsilateral facial and lateral rectus palsy, with contralateral limb hemiplegia. These symptoms are due to dysfunction of the abducens and facial nerves and interruption of the corticospinal tract.[19][20]

Ventral Medial Pontine Infarct (Raymond Syndrome)

This is a very rare pontine stroke with two subtypes: classic Raymond syndrome and common Raymond syndrome. The classic subtype presents as ipsilateral lateral rectus with contralateral facial nerve paralysis and limb hemiparesis secondary to medial midpontine infarct. The common subtype spares the face and is secondary to an infarct that does not include corticofacial fibers.[21][22]

Raymond–Cestan Syndrome

This syndrome is caused due to the lesion involving the upper dorsal pons. It manifests as ipsilateral ataxia and coarse intention tremor, ipsilateral paralysis of muscles of mastication and sensory loss in the face, contralateral sensory loss in the body, and contralateral hemiparesis of the face and the body. [23]

Gasperini Syndrome

This is a rare syndrome caused by impairment of the caudal pons tegmentum, which presents with ipsilateral CN V, VI, VII, and VIII impairment with contralateral limb hemianesthesia. This syndrome has been observed in demyelinating conditions like multiple sclerosis and ischemic events due to occlusion branches of the basilar and AICA arteries.[24][25]

Lateral Pontine Syndrome (Marie Foix Syndrome)

This is a rare brainstem stroke caused by occlusion of the long circumferential branches of the basilar artery or the anterior inferior cerebellar artery. This syndrome presents with ipsilateral peripheral facial nerve deficits with loss of facial pain and temperature, ipsilateral hypacusis, ipsilateral Horner syndrome, contralateral extremity hemiparesis, and pain and temperature sensory loss and extremity ataxia.[26] 

Weber Syndrome (Superior Alternating Hemiplegia

This presents from occlusion of paramedian branches of the posterior cerebral artery (PCA) or the basilar bifurcation perforating arteries in the midbrain. It presents with ipsilateral CN III palsy and contralateral hemiparesis of extremities and face. This syndrome can also present with vertical gaze paralysis if the ischemic region includes the red nucleus.[27]

Paramedian Midbrain Syndrome (Benedikt Syndrome)

Occlusion of the paramedian penetration branches of the basilar artery causes ipsilateral CN III palsy with contralateral loss of proprioception and vibration, and ataxia. It is separated from Weber syndrome in that this syndrome has a tremor and choreoathetotic movements, whereas Weber has hemiparesis.[28][29]


First responders perform prehospital stroke assessments to identify potential stroke patients quickly. There are many assessments; however, the most common one is the Cincinnati Prehospital Stroke Assessment, which assesses facial droop, arm drift, and speech. A last known well time should be obtained, which documents the last time a patient was observed at their baseline health to better triage eligible patients to transfer patients to primary or comprehensive stroke centers. At these centers, a neurologist performs a rapid initial assessment using the National Institute of Health’s Stroke Scale to localize strokes and document an initial standardized exam to monitor progression. This scale ranges from 0 to 42 and includes categories that assess the level of consciousness, best gaze, visual field, facial palsy, motor function in each limb, limb ataxia, sensation, language, dysarthria, extinction, and neglect.

A non-contrast CT of the head or brain MRI should be performed within 20 minutes of initial presentation to evaluate for intracranial hemorrhage. Vessel angiography using either a CT or MR scanner is obtained of the head and neck to evaluate for potential large vessel occlusion, which could be manually removed through a procedure known as thrombectomy to revascularize tissue at risk of ischemia. Hospitals without this imaging modality are recommended to call a teleradiology service to contact a stroke neurologist for advice on administering thrombolytics and further workup.

Blood glucose should be tested to rule out hypoglycemia as a cause of neurological deficits. Other workups will include a complete blood count and metabolic panel, troponin, and coagulation factors. An echocardiogram should be performed to rule out simultaneous cardiac disease.[30][31]

Treatment / Management

Treatment of strokes requires an interprofessional specialized team found at centers that specialize in stroke care. Team members include neurology, neurosurgery, neuro-intensivists, specialized nursing, rehabilitation medicine with physical, occupational, and speech therapists.

Ischemic Strokes

Treatment of ischemic strokes is time-dependent. If the onset of symptoms occurs before 4.5 hours without evidence of hemorrhage on a non-contrast CT scan, the patient is tissue plasminogen activator (TPA) eligible, the preferable agent being IV alteplase. The dose of alteplase is calculated as 0.9 mg/kg with a maximum dose of 90 mg. 10% of the total dose is given as a bolus over one minute, and the remainder is given over the next hour.  There is a set of inclusion criteria and contraindications that should be discussed with the patient to obtain informed consent before administering the medication. This is generally performed by a neurologist specializing in stroke; however, another physician can perform it with guidance. Most notable contraindications include recent intracranial surgery or trauma, active internal bleeding, intracranial hemorrhage, blood pressure greater than 180/90 mmHg. Inclusion criteria are stroke with a measurable neurological deficit occurring less than 4.5 hours. There are relative exclusion criteria for patients greater than 80 years old, NIHSS score greater than 25, and current anticoagulant use.[32]

While posterior circulation strokes were not included in the DAWN or DEFUSE-3 trials, recent studies have shown thrombectomy can be performed on posterior circulation ischemic strokes. These studies have also noted to have a lower rate of hemorrhage when compared to anterior circulation strokes. In this procedure, a puncture through the femoral artery at the groin is made to insert a clot retriever device to remove a thrombus obstructing a large intracranial vessel manually. Using fluoroscopic guidance, the degree of vessel recanalization is categorized as Thrombolysis In Cerebral Infarction (TICI) score is assigned 0 to 3, with TICI 3 representing complete perfusion.[33]

After treatment with TPA and/or thrombectomy, the patient is later observed in a neuro focused ICU setting for close monitoring of vitals. Blood pressure is permissively elevated to 180/90 mmHg to allow tissue reperfusion in the first 24 hours after the intervention. If no therapy is given, blood pressure is more permissive to 220/110 mmHg. Strict blood pressure can be controlled using IV antihypertensives such as nicardipine, clevidipine, hydralazine, or labetalol. Hourly neuro checks are also performed to assess for a change in their neurological exam to indicate an acute complication such as intracranial hemorrhage, edema with midline shift or herniation, or a repeat ischemic stroke. If a change is documented, a stat CT of the head without contrast should be obtained.

Hemorrhagic Strokes

This life-threatening condition requires an immediate neurosurgical assessment, depending on the extent of bleeding, and acute surgical intervention may be necessary depending on the site of hemorrhage. A head CTA should be performed to localize the hemorrhaged vessel to evaluate for surgical intervention. These cases should also be observed in a Neuro ICU setting. Hemorrhage into the ventricular space can obstruct CSF flow and may require placement of an extra ventricular drain through the scalp to manually drain CSF and reduce ventricular pressure. Hemorrhage into the parenchyma is generally monitored closely in the ICU for evaluation of midline shift. Blood pressure should be controlled using IV antihypertensives listed above to maintain pressure below 160/90 mmHg. Anticoagulant and pharmacological deep venous thrombosis (DVT) prophylaxis are recommended to be held in the acute management of this disease to prevent worsening intracranial bleeding.[32]

Differential Diagnosis

  • Benign positional paroxysmal vertigo
  • Brainstem migraine
  • Dolichoectasia of the vertebral or basilar artery
  • Intracranial tumor
  • Labrythnthitis
  • Postictal state with Todd paralysis
  • Thyroid disease
  • Transient ischemic attack
  • Vertebrobasilar insufficiency
  • Vestibular neuritis


The prognosis of vertebrobasilar strokes is dependent on the amount of brain ischemia and treatment provided. Prior baseline function, age, and ability to undergo physical therapy also drastically change expected outcomes.


Side effects of TPA include intracranial hemorrhage, nausea, angioedema of the tongue, which, if it develops, is promptly stabilized by holding TPA and ACE inhibitors, administering IV steroids, and intubation.[34]

A complication of large ischemic and hemorrhagic strokes is vasogenic or cytotoxic edema, causing increased intracranial pressure and mass effect, which shifts structures midline and downward, possibly compressing the brainstem, and in severe cases can herniate downwards through the foramen magnum. Before this occurs, patients can be given mannitol and/or hypertonic saline in hopes of preventing hemicraniectomy.[32]

Deterrence and Patient Education

Symptoms of sudden onset dizziness or nausea accompanied by loss of strength or sensation require immediate evaluation by a team of medical professionals as these can be symptoms of an acute stroke. Head imaging will be performed to confirm a stroke diagnosis and evaluate you for medical and surgical treatment. Prompt evaluation is necessary as one drug called TPA requires that you be evaluated within 4.5 hours of onset. If a blood clot is found and reachable, you may be a candidate for an intravascular procedure to remove the blood clot called a thrombectomy. The risk factors for having a stroke include high blood pressure, diabetes mellitus, high cholesterol, tobacco smoking, obesity, and a sedentary lifestyle.

Pearls and Other Issues

Vertebrobasilar strokes can be mistaken for another disease, given its nonspecific initial symptoms. Depending on the affected vessel, different brainstem stroke syndromes may be produced, which can cause new neurological deficits causing weakness, diminished vision, vertigo, confusion, or cranial nerve palsy. These red flag symptoms should raise the suspicion of an acute intracranial process, and these patients should be evaluated by a team that specializes in treating strokes as soon as the diagnosis is considered. Stroke evaluation includes a standardized screening method such as the NIH Stroke Scale, head imaging to evaluate for hemorrhage, and stenosed or occluded intracranial arteries, and magnetic resonance imaging of the brain. Secondary stroke workup includes evaluating for diabetes, hyperlipidemia, screening for a thrombus in the heart, and arrhythmia. Treatment with TPA should be offered as soon as possible after completing a contraindication standardized checklist discussed above.

Enhancing Healthcare Team Outcomes

Patients with acute vertigo, nausea or vomiting, and new neurological deficits should be evaluated promptly by stroke trained staff, including a neurologist, radiologist, or emergency department physician. Treatment with IV alteplase before 4.5 hours since the onset of symptoms is recommended—those who are treated with alteplase show favorable outcomes over those who went untreated. If imaging can localize a vessel occlusion, thrombectomy should be performed.

Vertebrobasilar stroke patients require the coordination of an interprofessional team, especially inasmuch as the differentials are not always clear and could delay much-needed intervention. This team will consist of clinicians, specialists, mid-level practitioners (PAs and NPs), pharmacists, and nursing staff, operating as a unit and communicating across disciplinary boundaries to render timely and optimal care that can significantly improve patient outcomes. [Level 5]

Article Details

Article Author

Benjamin Alwood

Article Editor:

Rimal Dossani


5/2/2022 9:58:04 AM

PubMed Link:

Vertebrobasilar Stroke



Boehme AK,Esenwa C,Elkind MS, Stroke Risk Factors, Genetics, and Prevention. Circulation research. 2017 Feb 3;     [PubMed PMID: 28154098]




Shi Y,Wardlaw JM, Update on cerebral small vessel disease: a dynamic whole-brain disease. Stroke and vascular neurology. 2016 Sep     [PubMed PMID: 28959468]


Guzik A,Bushnell C, Stroke Epidemiology and Risk Factor Management. Continuum (Minneapolis, Minn.). 2017 Feb;     [PubMed PMID: 28157742]


Demel SL,Broderick JP, Basilar Occlusion Syndromes: An Update. The Neurohospitalist. 2015 Jul;     [PubMed PMID: 26288672]


Xing C,Arai K,Lo EH,Hommel M, Pathophysiologic cascades in ischemic stroke. International journal of stroke : official journal of the International Stroke Society. 2012 Jul     [PubMed PMID: 22712739]


Lui F,Tadi P,Anilkumar AC, Wallenberg Syndrome 2019 Jan;     [PubMed PMID: 29262144]


Ogawa K,Suzuki Y,Oishi M,Kamei S, Clinical study of 46 patients with lateral medullary infarction. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association. 2015 May;     [PubMed PMID: 25817616]


Kim JS,Han YS, Medial medullary infarction: clinical, imaging, and outcome study in 86 consecutive patients. Stroke. 2009 Oct;     [PubMed PMID: 19628797]


Nandhagopal R,Krishnamoorthy SG,Srinivas D, Neurological picture. Medial medullary infarction. Journal of neurology, neurosurgery, and psychiatry. 2006 Feb;     [PubMed PMID: 16421124]


Toyoda K,Imamura T,Saku Y,Oita J,Ibayashi S,Minematsu K,Yamaguchi T,Fujishima M, Medial medullary infarction: analyses of eleven patients. Neurology. 1996 Nov;     [PubMed PMID: 8909419]


Mossuto-Agatiello L,Kniahynicki C, The hemimedullary syndrome: case report and review of the literature. Journal of neurology. 1990 Jun;     [PubMed PMID: 2196341]


Ortiz de Mendivil A,Alcalá-Galiano A,Ochoa M,Salvador E,Millán JM, Brainstem stroke: anatomy, clinical and radiological findings. Seminars in ultrasound, CT, and MR. 2013 Apr     [PubMed PMID: 23522778]


Ioannides K,Tadi P,Naqvi IA, Cerebellar Infarct 2019 Jan;     [PubMed PMID: 29261863]


Ng ZX,Yang WR,Seet E,Koh KM,Teo KJ,Low SW,Chou N,Yeo TT,Venketasubramanian N, Cerebellar strokes: a clinical outcome review of 79 cases. Singapore medical journal. 2015 Mar;     [PubMed PMID: 25820846]


Caplan LR,     [PubMed PMID: 7188637]


Ogawa K,Suzuki Y,Takahashi K,Kamei S,Ishikawa H, Clinical Study of Eleven Patients with Midbrain Infarction-Induced Oculomotor Nerve Palsy. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association. 2016 Jul;     [PubMed PMID: 27067886]


Khazaal O,Marquez DL,Naqvi IA, Foville Syndrome 2019 Jan;     [PubMed PMID: 31334988]


Sakuru R,Bollu PC, Millard Gubler Syndrome 2019 Jan;     [PubMed PMID: 30422502]


Bassetti C,Bogousslavsky J,Barth A,Regli F, Isolated infarcts of the pons. Neurology. 1996 Jan;     [PubMed PMID: 8559368]


Khan M,Naveed S,Haider I,Humayun M,Khan A, Classic Raymond Syndrome. Journal of the College of Physicians and Surgeons--Pakistan : JCPSP. 2017 Mar;     [PubMed PMID: 28406779]


Zaorsky NG,Luo JJ, A case of classic raymond syndrome. Case reports in neurological medicine. 2012;     [PubMed PMID: 22934209]


Krasnianski M,Wendt M,Müller T,Zierz S, Raymond-Cestan syndrome in pontine ischemia. Clinical neurology and neurosurgery. 2007 Nov;     [PubMed PMID: 17698284]


Krasnianski M,Müller T,Zierz S,Winterholler M, Gasperini syndrome as clinical manifestation of pontine demyelination. European journal of medical research. 2009 Sep 1;     [PubMed PMID: 19748860]


Hayashi-Hayata M,Nakayasu H,Doi M,Fukada Y,Murakami T,Nakashima K, Gasperini syndrome, a report of two cases. Internal medicine (Tokyo, Japan). 2007;     [PubMed PMID: 17268129]


Yoshioka T,Tokumitsu S,Goto K,Kuroiwa S,Okajima T, [Lateral inferior pontine syndrome: a case report]. Rinsho shinkeigaku = Clinical neurology. 1989 Jul;     [PubMed PMID: 2805519]


Muthu V,Kumar S,Prakash G,Sharma P,Varma S, Image diagnosis: Weber syndrome: a rare presentation of acute leukemia-a case report and review of the literature. The Permanente journal. 2015 Winter;     [PubMed PMID: 25663211]


Akdal G,Kutluk K,Men S,Yaka E, Benedikt and     [PubMed PMID: 15607218]


Schmidt D, [Classical brain stem syndrome. Definitions and history]. Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft. 2000 Jun;     [PubMed PMID: 10916384]


Hui C,Tadi P,Patti L, Ischemic Stroke 2019 Jan;     [PubMed PMID: 29763173]


Demaerschalk BM,Bobrow BJ,Raman R,Ernstrom K,Hoxworth JM,Patel AC,Kiernan TE,Aguilar MI,Ingall TJ,Dodick DW,Meyer BC, CT interpretation in a telestroke network: agreement among a spoke radiologist, hub vascular neurologist, and hub neuroradiologist. Stroke. 2012 Nov;     [PubMed PMID: 22984007]




Weber R,Minnerup J,Nordmeyer H,Eyding J,Krogias C,Hadisurya J,Berger K, Thrombectomy in posterior circulation stroke: differences in procedures and outcome compared to anterior circulation stroke in the prospective multicentre REVASK registry. European journal of neurology. 2019 Feb;     [PubMed PMID: 30218610]


Logallo N,Novotny V,Assmus J,Kvistad CE,Alteheld L,Rønning OM,Thommessen B,Amthor KF,Ihle-Hansen H,Kurz M,Tobro H,Kaur K,Stankiewicz M,Carlsson M,Morsund Å,Idicula T,Aamodt AH,Lund C,Næss H,Waje-Andreassen U,Thomassen L, Tenecteplase versus alteplase for management of acute ischaemic stroke (NOR-TEST): a phase 3, randomised, open-label, blinded endpoint trial. The Lancet. Neurology. 2017 Oct;     [PubMed PMID: 28780236]